Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,229,359
-
Share change
-
+15,229,059
-
Total reported value
-
$433,957,520
-
Price per share
-
$28.56
-
Number of holders
-
52
-
Value change
-
+$433,949,519
-
Number of buys
-
51
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q2 2018
As of 30 Jun 2018,
AVROBIO INC - COM (AVRO) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,229,359 shares.
The largest 10 holders included
Clarus Ventures, LLC, SV Health Investors, LLC, CITADEL ADVISORS LLC, Cormorant Asset Management, LP, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and JPMORGAN CHASE & CO.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.